Our study establishes that myeloid-specific Tet2 deficiency exacerbates liver fibrosis through the Ccl2/Ccl8–pMDMs–IL-6–HSCs axis, with Tet2−/− pMDMs driving chemokine production, MDMs infiltration, and HSCs activation. The gene discussed is TET2; the disease is Hepatic fibrosis.